Nucorion Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2015-01-01
- Employees
- -
- Market Cap
- -
Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B
Phase 1
Completed
- Conditions
- Chronic Hepatitis B
- Interventions
- First Posted Date
- 2020-11-16
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Nucorion Pharmaceuticals, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT04629976
- Locations
- 🇺🇸
National Institute of Clinical Research, Inc, Monterey Park, California, United States
Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects
- First Posted Date
- 2020-03-16
- Last Posted Date
- 2020-11-03
- Lead Sponsor
- Nucorion Pharmaceuticals, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT04309526
- Locations
- 🇺🇸
Medpace Clinical Pharmacology Unit, Cincinnati, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath